Cargando…

Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration

Mitochondrial dysfunction and altered proteostasis are central features of neurodegenerative diseases. The pitrilysin metallopeptidase 1 (PITRM1) is a mitochondrial matrix enzyme, which digests oligopeptides, including the mitochondrial targeting sequences that are cleaved from proteins imported acr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunetti, Dario, Torsvik, Janniche, Dallabona, Cristina, Teixeira, Pedro, Sztromwasser, Pawel, Fernandez‐Vizarra, Erika, Cerutti, Raffaele, Reyes, Aurelio, Preziuso, Carmela, D'Amati, Giulia, Baruffini, Enrico, Goffrini, Paola, Viscomi, Carlo, Ferrero, Ileana, Boman, Helge, Telstad, Wenche, Johansson, Stefan, Glaser, Elzbieta, Knappskog, Per M, Zeviani, Massimo, Bindoff, Laurence A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772954/ https://www.ncbi.nlm.nih.gov/pubmed/26697887 http://dx.doi.org/10.15252/emmm.201505894

Ejemplares similares

Role of PITRM1 in Mitochondrial Dysfunction and Neurodegeneration
por: Brunetti, Dario, et al.
Publicado: (2021)

Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer’s disease-like pathology in human cerebral organoids
por: Pérez, María José, et al.
Publicado: (2020)

PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients
por: Di Donfrancesco, Alessia, et al.
Publicado: (2023)

In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration
por: Hytönen, Marjo K., et al.
Publicado: (2021)

DNA polymerase γ and disease: what we have learned from yeast
por: Lodi, Tiziana, et al.
Publicado: (2015)

Mitochondrial Aminoacyl-tRNA Synthetase and Disease: The Yeast Contribution for Functional Analysis of Novel Variants
por: Figuccia, Sonia, et al.
Publicado: (2021)

Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer’s disease
por: Du, Fang, et al.
Publicado: (2021)

GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies
por: Haugarvoll, Kristoffer, et al.
Publicado: (2017)

The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases
por: Ceccatelli Berti, Camilla, et al.
Publicado: (2021)

Familial amyloidotic polyneuropathy in Crete, Greece
por: Tzagournissakis, Minas, et al.
Publicado: (2015)

Glial cells in familial amyloidotic polyneuropathy
por: Gonçalves, Nádia Pereira, et al.
Publicado: (2014)

Saccharomyces cerevisiae as a Tool for Studying Mutations in Nuclear Genes Involved in Diseases Caused by Mitochondrial DNA Instability
por: Gilea, Alexandru Ionut, et al.
Publicado: (2021)

PNKP Mutations Identified by Whole-Exome Sequencing in a Norwegian Patient with Sporadic Ataxia and Edema
por: Tzoulis, C., et al.
Publicado: (2016)

Structural rather than catalytic role for mitochondrial respiratory chain supercomplexes
por: Brischigliaro, Michele, et al.
Publicado: (2023)

Mitochondrial Cytochrome c Oxidase Defects Alter Cellular Homeostasis of Transition Metals
por: Brischigliaro, Michele, et al.
Publicado: (2022)

Frequency of Cardiovascular Involvement in Familial Amyloidotic Polyneuropathy in Brazilian Patients
por: Queiroz, Márcia Cavalcanti de Campos, et al.
Publicado: (2015)

MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy
por: Martins, Diana, et al.
Publicado: (2017)

Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy
por: García de León, Sira Carrasco, et al.
Publicado: (2017)

Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex
por: Gilberti, Micol, et al.
Publicado: (2018)

Nuclear gene mutations as the cause of mitochondrial complex III deficiency
por: Fernández-Vizarra, Erika, et al.
Publicado: (2015)

Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice
por: Viscomi, Carlo, et al.
Publicado: (2009)

Transthyretin-related familial amyloidotic polyneuropathy—Progress in Kumamoto, Japan (1967–2010)—
por: ARAKI, Shukuro, et al.
Publicado: (2010)

Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis
por: Hund, Ernst
Publicado: (2012)

Novel SACS Mutations Identified by Whole Exome Sequencing in a Norwegian Family with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
por: Tzoulis, Charalampos, et al.
Publicado: (2013)

Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae
por: Baruffini, Enrico, et al.
Publicado: (2015)

Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
por: Chu, Jin, et al.
Publicado: (2012)

Long-Term Outcomes and Complications of Trabeculectomy for Secondary Glaucoma in Patients with Familial Amyloidotic Polyneuropathy
por: Kawaji, Takahiro, et al.
Publicado: (2014)

De novo intraocular amyloid deposition after hepatic transplantation in familial amyloidotic polyneuropathy
por: Gama, Ivo Filipe, et al.
Publicado: (2017)

Mitochondrial Neurodegeneration: Lessons from Drosophila melanogaster Models
por: Brischigliaro, Michele, et al.
Publicado: (2023)

MtDNA-maintenance defects: syndromes and genes
por: Viscomi, Carlo, et al.
Publicado: (2017)

Mitochondrial Neurodegeneration
por: Zeviani, Massimo, et al.
Publicado: (2022)

Familial amyloidotic polyneuropathy with muscle, vitreous, leptomeningeal, and cardiac involvement: Phenotypic, pathological, and MRI description
por: Prashantha, D. K., et al.
Publicado: (2010)

Beyond Genetic Factors in Familial Amyloidotic Polyneuropathy: Protein Glycation and the Loss of Fibrinogen's Chaperone Activity
por: da Costa, Gonçalo, et al.
Publicado: (2011)

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
por: Suhr, Ole B, et al.
Publicado: (2015)

Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models
por: Magistrati, Martina, et al.
Publicado: (2023)

Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae
por: Magistrati, Martina, et al.
Publicado: (2023)

Amyloid‐β in mitochondrial disease: mutation in a human metallopeptidase links amyloidotic neurodegeneration with mitochondrial processing
por: Boczonadi, Veronika, et al.
Publicado: (2016)

Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
por: Contesse, Sebastián E Azorín, et al.
Publicado: (2015)

Tissue remodeling after RNAi-mediated knockdown of TTR in a Familial Amyloidotic Polyneuropathy mouse model
por: Gonçalves, Nádia Pereira, et al.
Publicado: (2015)

Familial amyloidotic polyneuropathy associated with the transthyretin CYS 114 gene in a Russian pair of monozygotic twins.
por: Igor, Igor Srokov, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dotkoackdarpv17guqd8pgg8tl